Colon cancer is the second leading cause of cancer death in the United States, and it is estimated that it will claim the lives of 50,000 Americans this year. Because of the prevalence of the disease colon cancer research is constantly changing doctors’ approaches to treatment. New findings give birth to new treatments all in the hopes to prolong the quality and quantity of life in colon cancer patients.
New research suggests that risk of colon cancer can be reduced by estrogen. Although there is no specific estrogen therapy that exists at this time, this finding may be groundbreaking in future treatments. Signals sent by estrogen can delay or prevent colon cancer development, but researchers know very little about how this actually works.
Professor Cecelia Williams of the University of Houston has been awarded a $1.56 million grant from the National Cancer Institute to study molecular pathways that affect colon cancer development, prevention and treatment. The goal of the project, according to Williams, is to “increase opportunities for improved colon cancer prevention and therapies.” This five-year project involves the collaboration of graduate students and a team of researchers. The researchers hope to determine specific biomarkers associated with estrogen and colon cancer (Source: BioNews).
Every year, enhanced research and new discoveries give more hope to men and women who are fighting colon cancer. New treatments give patients and their families renewed hope in finding a cure for colon cancer and making treatments more efficient and effective. Do your part in the fight against colon cancer to stay current with colon cancer news. You can do this by regularly visiting the StopColonCancerNow.com website and reading the Butt Seriously Blog each week. News articles, recipes, survivor stories and special interest articles are posted regularly, so stay involved and share what you learn with a friend or family member.